Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations
1 The activity of angiotensin converting enzyme (ACE) has been studied on functional parameters of intact isolated preparations of extrapulmonary tissues. The conversion of angiotensin I (A I) to angiotensin II (A II) and the cleavage of bradykinin (BK) were used as indicators of ACE activity. Capto...
Saved in:
Published in | British journal of pharmacology Vol. 100; no. 1; pp. 49 - 54 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.05.1990
Nature Publishing |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | 1
The activity of angiotensin converting enzyme (ACE) has been studied on functional parameters of intact isolated preparations of extrapulmonary tissues. The conversion of angiotensin I (A I) to angiotensin II (A II) and the cleavage of bradykinin (BK) were used as indicators of ACE activity. Captopril was employed as a specific inhibitor of ACE.
2
Captopril augmented the BK‐induced contractions of the rat isolated uterus, the BK‐ and substance P‐induced contractions of the guinea‐pig ileum, and the BK‐induced venoconstriction in the isolated perfused ear of the rabbit. Degradation of BK by ACE was calculated to be 52% in the rat uterus and 75% in the rabbit perfused ear.
3
Captopril inhibited the A I‐induced contractions of the rat isolated colon, the A I‐induced vasoconstriction in the isolated perfused ear of the rabbit and the rise in blood pressure induced by i.a. injections of A I in pithed rats. Conversion of A I to A II was calculated to be 13% in the rat colon and 26% in the rabbit perfused ear.
4
From estimations of the A II activity (bioassay on the rat colon) in the effluent of the perfused ear of the rabbit after injections of A I into the arterial inflow cannula it was calculated that approximately one tenth of A I was converted to A II during a single passage through the ear (less than 15 s).
5
The present experiments suggest that the high activity of ACE in endothelium of blood vessels of extrapulmonary tissues may provide an additional (endothelium‐dependent) local vasoconstrictor mechanism by the rapid formation of A II and inactivation of BK. The ACE activity in non‐vascular smooth muscles, other than those of blood vessels, may also affect the physiological functions of these tissues. |
---|---|
AbstractList | 1. The activity of angiotensin converting enzyme (ACE) has been studied on functional parameters of intact isolated preparations of extrapulmonary tissues. The conversion of angiotensin I (A I) to angiotensin II (A II) and the cleavage of bradykinin (BK) were used as indicators of ACE activity. Captopril was employed as a specific inhibitor of ACE. 2. Captopril augmented the BK-induced contractions of the rat isolated uterus, the BK- and substance P-induced contractions of the guinea-pig ileum, and the BK-induced venoconstriction in the isolated perfused ear of the rabbit. Degradation of BK by ACE was calculated to be 52% in the rat uterus and 75% in the rabbit perfused ear. 3. Captopril inhibited the A I-induced contractions of the rat isolated colon, the A I-induced vasoconstriction in the isolated perfused ear of the rabbit and the rise in blood pressure induced by i.a. injections of A I in pithed rats. Conversion of A I to A II was calculated to be 13% in the rat colon and 26% in the rabbit perfused ear. 4. From estimations of the A II activity (bioassay on the rat colon) in the effluent of the perfused ear of the rabbit after injections of A I into the arterial inflow cannula it was calculated that approximately one tenth of A I was converted to A II during a single passage through the ear (less than 15 s). 5. The present experiments suggest that the high activity of ACE in endothelium of blood vessels of extrapulmonary tissues may provide an additional (endothelium-dependent) local vasoconstrictor mechanism by the rapid formation of A II and inactivation of BK. The ACE activity in non-vascular smooth muscles, other than those of blood vessels, may also affect the physiological functions of these tissues. 1. The activity of angiotensin converting enzyme (ACE) has been studied on functional parameters of intact isolated preparations of extrapulmonary tissues. The conversion of angiotensin I (A I) to angiotensin II (A II) and the cleavage of bradykinin (BK) were used as indicators of ACE activity. Captopril was employed as a specific inhibitor of ACE. 2. Captopril augmented the BK-induced contractions of the rat isolated uterus, the BK- and substance P-induced contractions of the guinea-pig ileum, and the BK-induced venoconstriction in the isolated perfused ear of the rabbit. Degradation of BK by ACE was calculated to be 52% in the rat uterus and 75% in the rabbit perfused ear. 3. Captopril inhibited the A I-induced contractions of the rat isolated colon, the A I-induced vasoconstriction in the isolated perfused ear of the rabbit and the rise in blood pressure induced by i.a. injections of A I in pithed rats. Conversion of A I to A II was calculated to be 13% in the rat colon and 26% in the rabbit perfused ear. 4. From estimations of the A II activity (bioassay on the rat colon) in the effluent of the perfused ear of the rabbit after injections of A I into the arterial inflow cannula it was calculated that approximately one tenth of A I was converted to A II during a single passage through the ear (less than 15 s). The activity of angiotensin converting enzyme (ACE) has been studied on functional parameters of intact isolated preparations of extrapulmonary tissues. The conversion of angiotensin I (A I) to angiotensin II (A II) and the cleavage of bradykinin (BK) were used as indicators of ACE activity. Captopril was employed as a specific inhibitor of ACE. Captopril augmented the BK-induced contractions of the rat isolated uterus, the BK- and substance P-induced contractions of the guinea-pig ileum, and the BK-induced venoconstriction in the isolated perfused ear of the rabbit. Degradation of BK by ACE was calculated to be 52% in the rat uterus and 75% in the rabbit perfused ear. 1 The activity of angiotensin converting enzyme (ACE) has been studied on functional parameters of intact isolated preparations of extrapulmonary tissues. The conversion of angiotensin I (A I) to angiotensin II (A II) and the cleavage of bradykinin (BK) were used as indicators of ACE activity. Captopril was employed as a specific inhibitor of ACE. 2 Captopril augmented the BK‐induced contractions of the rat isolated uterus, the BK‐ and substance P‐induced contractions of the guinea‐pig ileum, and the BK‐induced venoconstriction in the isolated perfused ear of the rabbit. Degradation of BK by ACE was calculated to be 52% in the rat uterus and 75% in the rabbit perfused ear. 3 Captopril inhibited the A I‐induced contractions of the rat isolated colon, the A I‐induced vasoconstriction in the isolated perfused ear of the rabbit and the rise in blood pressure induced by i.a. injections of A I in pithed rats. Conversion of A I to A II was calculated to be 13% in the rat colon and 26% in the rabbit perfused ear. 4 From estimations of the A II activity (bioassay on the rat colon) in the effluent of the perfused ear of the rabbit after injections of A I into the arterial inflow cannula it was calculated that approximately one tenth of A I was converted to A II during a single passage through the ear (less than 15 s). 5 The present experiments suggest that the high activity of ACE in endothelium of blood vessels of extrapulmonary tissues may provide an additional (endothelium‐dependent) local vasoconstrictor mechanism by the rapid formation of A II and inactivation of BK. The ACE activity in non‐vascular smooth muscles, other than those of blood vessels, may also affect the physiological functions of these tissues. The activity of angiotensin converting enzyme (ACE) has been studied on functional parameters of intact isolated preparations of extrapulmonary tissues. The conversion of angiotensin I (A I) to angiotensin II (A II) and the cleavage of bradykinin (BK) were used as indicators of ACE activity. Captopril was employed as a specific inhibitor of ACE. Captopril augmented the BK‐induced contractions of the rat isolated uterus, the BK‐ and substance P‐induced contractions of the guinea‐pig ileum, and the BK‐induced venoconstriction in the isolated perfused ear of the rabbit. Degradation of BK by ACE was calculated to be 52% in the rat uterus and 75% in the rabbit perfused ear. Captopril inhibited the A I‐induced contractions of the rat isolated colon, the A I‐induced vasoconstriction in the isolated perfused ear of the rabbit and the rise in blood pressure induced by i.a. injections of A I in pithed rats. Conversion of A I to A II was calculated to be 13% in the rat colon and 26% in the rabbit perfused ear. From estimations of the A II activity (bioassay on the rat colon) in the effluent of the perfused ear of the rabbit after injections of A I into the arterial inflow cannula it was calculated that approximately one tenth of A I was converted to A II during a single passage through the ear (less than 15 s). The present experiments suggest that the high activity of ACE in endothelium of blood vessels of extrapulmonary tissues may provide an additional (endothelium‐dependent) local vasoconstrictor mechanism by the rapid formation of A II and inactivation of BK. The ACE activity in non‐vascular smooth muscles, other than those of blood vessels, may also affect the physiological functions of these tissues. |
Author | Griesbacher, T. Lembeck, F. Eckhardt, M. |
AuthorAffiliation | Department of Experimental and Clinical Pharmacology, University of Graz, Austria |
AuthorAffiliation_xml | – name: Department of Experimental and Clinical Pharmacology, University of Graz, Austria |
Author_xml | – sequence: 1 givenname: F. surname: Lembeck fullname: Lembeck, F. – sequence: 2 givenname: T. surname: Griesbacher fullname: Griesbacher, T. – sequence: 3 givenname: M. surname: Eckhardt fullname: Eckhardt, M. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=6876190$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/2164861$$D View this record in MEDLINE/PubMed |
BookMark | eNqVUV2L1DAUDbKyzq7-BKGI-NZukrb58EHUVXeFBX3Q55BmbscMbVKbdJzx12_qlMF9EkMgyT3nHu7JuUBnzjtA6AXBBUnraluQirO8LgUpiJS4iA2huMbF_hFanaAztMIY85wQIZ6gixC2GCeQ1-fonBJWCUZWaPMBeu9CHHW03mW-zWCfHsPUpbIeD5k20e5sPMyQdhvrI7hgXWa828EYrdtk4H4feshS0bqY-Fm0IUyQDSMM-igcnqLHre4CPFvOS_T908dv17f53Zebz9fv7nKTRsb5mpUEQ1WzplzXUJVU8IqyBrQptWTUaFmRVpZC0oY3opKmbTGldc1rtqaG4fISvTnqDlPTw9qAS246NYy2T26U11Y9RJz9oTZ-p4gkvGIkCbxaBEb_c4IQVW-Dga7TDvwUFJdCpC3-SSQ1oyw5SMTXR6IZfQgjtKdpCFZznmqr5tDUHJqa81RLnmqfmp__7efUugSY8JcLroPRXTtqZ2w40ZjgjMj5W94eab9sB4f_GEC9_3r751reA_HSwlw |
CODEN | BJPCBM |
CitedBy_id | crossref_primary_10_1111_ced_12106 crossref_primary_10_1016_j_jff_2015_06_008 crossref_primary_10_1016_0014_2999_91_90701_Q crossref_primary_10_1016_0196_9781_93_90091_T crossref_primary_10_1016_S0196_9781_97_00065_X crossref_primary_10_1111_j_1476_5381_1992_tb12751_x crossref_primary_10_7705_biomedica_v29i4_128 |
Cites_doi | 10.1161/01.RES.26.5.591 10.1016/0005-2744(71)90142-2 10.1097/00004872-198707002-00013 10.1152/ajplegacy.1962.203.2.261 10.1111/j.1476-5381.1964.tb01591.x 10.1016/0024-3205(68)90086-6 10.1007/BF00173408 10.1111/j.2042-7158.1980.tb12833.x 10.1111/j.1476-5381.1986.tb10178.x 10.1161/01.HYP.6.2.216 10.1001/archderm.1980.01640320052013 10.3181/00379727-64-15828 10.1126/science.175444 10.1016/S0196-9781(81)80027-7 10.1139/y81-022 10.1016/0006-2952(80)90603-6 10.1016/0024-3205(82)90641-5 10.1111/j.1476-5381.1989.tb11850.x 10.1111/j.1476-5381.1989.tb12599.x 10.1007/BF00581069 10.1007/BF00169123 10.1016/0196-9781(84)90020-2 10.1016/0014-2999(84)90225-5 10.1111/j.1476-5381.1967.tb02148.x 10.1007/BF01897474 10.1038/218144a0 10.1097/00004872-198812040-00004 |
ContentType | Journal Article |
Copyright | 1990 British Pharmacological Society 1990 INIST-CNRS |
Copyright_xml | – notice: 1990 British Pharmacological Society – notice: 1990 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 8FD C1K FR3 M81 P64 7X8 5PM |
DOI | 10.1111/j.1476-5381.1990.tb12050.x |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Bacteriology Abstracts (Microbiology B) Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biochemistry Abstracts 3 Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Engineering Research Database Technology Research Database Biochemistry Abstracts 3 Bacteriology Abstracts (Microbiology B) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Engineering Research Database CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1476-5381 |
EndPage | 54 |
ExternalDocumentID | 10_1111_j_1476_5381_1990_tb12050_x 2164861 6876190 BPH12050 |
Genre | shortCommunication Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .3N .55 .GJ 05W 0R~ 1OC 23N 24P 2WC 31~ 33P 36B 3O- 3SF 3V. 4.4 52U 52V 53G 5GY 6J9 7RV 7X7 8-0 8-1 88E 8AO 8FE 8FH 8FI 8FJ 8R4 8R5 8UM A00 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCUV ABDBF ABPVW ABQWH ABUWG ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFKRA AFPWT AFRAH AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB B0M BAFTC BAWUL BBNVY BENPR BFHJK BHBCM BHPHI BKEYQ BMXJE BPHCQ BRXPI BVXVI C45 CAG CCPQU COF CS3 DCZOG DIK DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EAS EBC EBD EBS ECV EJD EMB EMK EMOBN ENC ESX EX3 F5P FUBAC FYUFA G-S GODZA GX1 H.X HCIFZ HGLYW HMCUK HYE HZ~ J5H KBYEO LATKE LEEKS LH4 LITHE LK8 LOXES LSO LUTES LW6 LYRES M1P M7P MEWTI MK0 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N9A NAPCQ NF~ O66 O9- OIG OK1 OVD P2P P2W P4E PQQKQ PROAC PSQYO Q.N Q2X QB0 RIG ROL RPM RWI SJN SUPJJ SV3 TEORI TR2 TUS UKHRP UPT WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WVDHM WXSBR X7M XV2 Y6R YHG ZGI ZXP ZZTAW ~8M ~S- 08R AAJUZ AAPBV AAUGY AAVGM ABCVL ABHUG ABPTK ABWRO ACXME ADAWD ADDAD AFVGU AGJLS IQODW ZA5 CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 8FD C1K FR3 M81 P64 7X8 5PM |
ID | FETCH-LOGICAL-c5380-d6310e456b3d5e43287426beac3a962ca941f93892b7b849cff02255756d2c603 |
IEDL.DBID | RPM |
ISSN | 0007-1188 |
IngestDate | Tue Sep 17 21:27:16 EDT 2024 Fri Oct 25 09:35:03 EDT 2024 Sat Oct 26 01:20:14 EDT 2024 Fri Aug 23 03:42:39 EDT 2024 Sat Sep 28 08:33:04 EDT 2024 Sun Oct 29 17:09:43 EDT 2023 Sat Aug 24 00:58:39 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Gut Enzyme inhibitor Smooth muscle Muscle contraction In vitro Biological activity Endothelium Uterus Animal Blood vessel Angiotensin converting enzyme Blood pressure Mechanism of action |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5380-d6310e456b3d5e43287426beac3a962ca941f93892b7b849cff02255756d2c603 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://europepmc.org/articles/pmc1917461?pdf=render |
PMID | 2164861 |
PQID | 15626432 |
PQPubID | 23462 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_1917461 proquest_miscellaneous_79889888 proquest_miscellaneous_15626432 crossref_primary_10_1111_j_1476_5381_1990_tb12050_x pubmed_primary_2164861 pascalfrancis_primary_6876190 wiley_primary_10_1111_j_1476_5381_1990_tb12050_x_BPH12050 |
PublicationCentury | 1900 |
PublicationDate | May 1990 |
PublicationDateYYYYMMDD | 1990-05-01 |
PublicationDate_xml | – month: 05 year: 1990 text: May 1990 |
PublicationDecade | 1990 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Basingstoke – name: England |
PublicationTitle | British journal of pharmacology |
PublicationTitleAlternate | Br J Pharmacol |
PublicationYear | 1990 |
Publisher | Blackwell Publishing Ltd Nature Publishing |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Nature Publishing |
References | 1968; 7 1962; 203 1974; 37 1980; 116 1965; 148 1983; 398 1980; 29 1986; 332 1984; 100 1982; 30 1987; 5 1981; 2 1947; 64 1964; 23 1976; 191 1968; 218 1989; 96 1976; 198 1989; 98 1986; 87 1987; 335 1988; 6 1984; 6 1967; 30 1980; 32 1984; 5 1969; 25 1981; 59 1984 1981 1980 1971; 250 1988; 338 1970; 26 GEIGY (e_1_2_1_6_1) 1980 e_1_2_1_20_1 e_1_2_1_23_1 CARRETERO O.A. (e_1_2_1_3_1) 1981 e_1_2_1_21_1 e_1_2_1_22_1 e_1_2_1_27_1 e_1_2_1_28_1 e_1_2_1_25_1 e_1_2_1_26_1 e_1_2_1_29_1 WILKIN J.K. (e_1_2_1_34_1) 1980; 116 e_1_2_1_31_1 e_1_2_1_8_1 e_1_2_1_5_1 McCARTHY D.A. (e_1_2_1_13_1) 1965; 148 SCHÖLKENS B.A. (e_1_2_1_24_1) 1986; 332 e_1_2_1_12_1 e_1_2_1_4_1 e_1_2_1_10_1 e_1_2_1_33_1 e_1_2_1_2_1 e_1_2_1_11_1 e_1_2_1_32_1 e_1_2_1_16_1 e_1_2_1_17_1 e_1_2_1_14_1 e_1_2_1_15_1 GOLDBERG M.R. (e_1_2_1_7_1) 1976; 198 VANE J.R. (e_1_2_1_30_1) 1974 ZAR J.A. (e_1_2_1_35_1) 1984 e_1_2_1_9_1 e_1_2_1_18_1 e_1_2_1_19_1 |
References_xml | – volume: 398 start-page: 175 year: 1983 end-page: 177 article-title: The effect of kininase II inhibitors on the response of feline cerebral arteries to bradykinin and angiotensin publication-title: Pflügers Arch. (Eur. J. Physiol.) – volume: 250 start-page: 261 year: 1971 end-page: 265 article-title: Concentrations of angiotensin‐converting enzyme in tissues of the rat publication-title: Biochim. Biophys. Acta – volume: 2 start-page: 145 year: 1981 end-page: 152 article-title: Purification and characterization of human converting enzyme (kininase II) publication-title: Peptides – volume: 332 start-page: R60 issue: Suppl. year: 1986 article-title: Inhibition of converting enzyme in isolated arterial preparations with intact or disrupted endothelium publication-title: Naunyn-Schmiedebergs Arch. Pharmacol. – volume: 96 start-page: 531 year: 1989 end-page: 538 article-title: Effects of the bradykinin antagonist B4310 on smooth muscles and blood pressure in the rat, and its enzymatic degradation publication-title: Br. J. Pharmacol. – start-page: 105 year: 1981 end-page: 121 – volume: 218 start-page: 144 year: 1968 end-page: 150 article-title: Fate of angiotensin I in the circulation publication-title: Nature – volume: 203 start-page: 261 year: 1962 end-page: 265 article-title: Bradykinin and cardiovascular system: estimation of half‐life publication-title: Am. J. Physiol. – volume: 59 start-page: 131 year: 1981 end-page: 138 article-title: The degradation of bradykinin (Bk) and of des‐Arg ‐Bk in plasma publication-title: Can. J. Physiol. Pharmacol. – volume: 87 start-page: 249 year: 1986 end-page: 255 article-title: Role of endothelium on the facilitatory effects of angiotensin I and angiotensin II on noradrenergic transmission in the caudal artery of the rat publication-title: Br. J. Pharmacol. – volume: 198 start-page: 357 year: 1976 end-page: 365 article-title: Influence of prostaglandin synthesis on venoconstrictor responses to bradykinin publication-title: J. Pharmacol. Exp. Ther. – volume: 37 start-page: 17 year: 1974 end-page: 40 – volume: 32 start-page: 1 year: 1980 end-page: 46 article-title: Pharmacology of bradykinin and related kinins publication-title: Pharmacol. Rev. – volume: 23 start-page: 351 year: 1964 end-page: 359 article-title: A sensitive method for the assay of angiotensin publication-title: Br. J. Pharmacol. – volume: 29 start-page: 1525 year: 1980 end-page: 1529 article-title: Angiotensin I converting enzyme (kininase II) of brush border of human and swine intestine publication-title: Biochem. Pharmacol. – volume: 148 start-page: 117 year: 1965 end-page: 122 article-title: An estimation of the potencies and half‐lives of synthetic bradykinin and kallidin publication-title: J. Pharmacol. Exp. Ther. – volume: 30 start-page: 99 year: 1982 end-page: 106 article-title: Renin synthesis by canine aortic smooth muscle cells in culture publication-title: Life Sci. – volume: 6 start-page: 216 year: 1984 end-page: 222 article-title: Role of endothelium in conversion of angiotensin I to angiotensin II in rabbit aorta publication-title: Hypertension – volume: 98 start-page: 333 year: 1989 end-page: 335 article-title: Angiotensin converting enzyme activity is present in the endothelium‐denuded aorta publication-title: Br. J. Pharmacol. – volume: 25 start-page: 1247 year: 1969 article-title: Converting enzyme content of different tissues of the rat publication-title: Experientia – year: 1984 – volume: 191 start-page: 1050 year: 1976 end-page: 1051 article-title: Angiotensin converting enzyme: vascular endothelial localization publication-title: Science – volume: 6 start-page: S25 issue: suppl. 4 year: 1988 end-page: S28 article-title: Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist publication-title: J. Hypertension – year: 1980 – volume: 338 start-page: 327 year: 1988 end-page: 331 article-title: Angiotensinogen gene expression in extrahepatic rat tissues: Application of a solution hybridization assay publication-title: Naunyn-Schmiedebergs Arch. Pharmacol. – volume: 335 start-page: 551 year: 1987 end-page: 554 article-title: Metabolism of bradykinin and angiotensin I by human basilar artery and rabbit aorta publication-title: Naunyn-Schmiedebergs Arch. Pharmacol. – volume: 5 start-page: 769 year: 1984 end-page: 776 article-title: Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase publication-title: Peptides – volume: 64 start-page: 453 year: 1947 end-page: 455 article-title: A pithed rat preparation suitable for assaying pressor substances publication-title: Proc. Soc. Exp. Biol. Med. – volume: 30 start-page: 417 year: 1967 end-page: 424 article-title: The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat publication-title: Br. J. Pharmacol. Chemother. – volume: 100 start-page: 211 year: 1984 end-page: 217 article-title: Intima‐related vasodilatation of the perfused rat caudal artery publication-title: Eur. J. Pharmacol. – volume: 116 start-page: 902 year: 1980 end-page: 905 article-title: The captopril‐induced eruption. A possible mechanism: cutaneous kinin potentiation publication-title: Arch. Dermatol. – volume: 7 start-page: 633 year: 1968 end-page: 639 article-title: A simple method for the determination of angiotensin I converting enzyme publication-title: Life Sci. – volume: 26 start-page: 591 year: 1970 end-page: 599 article-title: and conversion of angiotensin I to angiotensin II in dog blood publication-title: Circ. Res. – volume: 5 start-page: S71 issue: suppl. 2 year: 1987 end-page: S76 article-title: Effects of teprotide, captopril and enalaprilat on arterial wall kininase and angiotensin converting activity publication-title: J. Hypertension – ident: e_1_2_1_15_1 doi: 10.1161/01.RES.26.5.591 – ident: e_1_2_1_4_1 doi: 10.1016/0005-2744(71)90142-2 – ident: e_1_2_1_11_1 doi: 10.1097/00004872-198707002-00013 – ident: e_1_2_1_21_1 doi: 10.1152/ajplegacy.1962.203.2.261 – ident: e_1_2_1_19_1 doi: 10.1111/j.1476-5381.1964.tb01591.x – ident: e_1_2_1_10_1 doi: 10.1016/0024-3205(68)90086-6 – ident: e_1_2_1_9_1 doi: 10.1007/BF00173408 – ident: e_1_2_1_18_1 doi: 10.1111/j.2042-7158.1980.tb12833.x – ident: e_1_2_1_29_1 doi: 10.1111/j.1476-5381.1986.tb10178.x – start-page: 105 volume-title: Angiotensin Converting Enzyme Inhibitors. Mechanism of Action and Clinical Applications year: 1981 ident: e_1_2_1_3_1 contributor: fullname: CARRETERO O.A. – ident: e_1_2_1_22_1 doi: 10.1161/01.HYP.6.2.216 – volume: 116 start-page: 902 year: 1980 ident: e_1_2_1_34_1 article-title: The captopril‐induced eruption. A possible mechanism: cutaneous kinin potentiation publication-title: Arch. Dermatol. doi: 10.1001/archderm.1980.01640320052013 contributor: fullname: WILKIN J.K. – ident: e_1_2_1_25_1 doi: 10.3181/00379727-64-15828 – ident: e_1_2_1_2_1 doi: 10.1126/science.175444 – ident: e_1_2_1_28_1 doi: 10.1016/S0196-9781(81)80027-7 – volume: 198 start-page: 357 year: 1976 ident: e_1_2_1_7_1 article-title: Influence of prostaglandin synthesis on venoconstrictor responses to bradykinin publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: GOLDBERG M.R. – ident: e_1_2_1_12_1 doi: 10.1139/y81-022 – start-page: 17 volume-title: Angiotensin, Handb. Exp. Pharmacol year: 1974 ident: e_1_2_1_30_1 contributor: fullname: VANE J.R. – ident: e_1_2_1_31_1 doi: 10.1016/0006-2952(80)90603-6 – ident: e_1_2_1_17_1 doi: 10.1016/0024-3205(82)90641-5 – ident: e_1_2_1_8_1 doi: 10.1111/j.1476-5381.1989.tb11850.x – ident: e_1_2_1_16_1 doi: 10.1111/j.1476-5381.1989.tb12599.x – ident: e_1_2_1_33_1 doi: 10.1007/BF00581069 – volume: 148 start-page: 117 year: 1965 ident: e_1_2_1_13_1 article-title: An in vivo estimation of the potencies and half‐lives of synthetic bradykinin and kallidin publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: McCARTHY D.A. – ident: e_1_2_1_32_1 doi: 10.1007/BF00169123 – volume-title: Biostatistical Analysis year: 1984 ident: e_1_2_1_35_1 contributor: fullname: ZAR J.A. – ident: e_1_2_1_26_1 doi: 10.1016/0196-9781(84)90020-2 – ident: e_1_2_1_27_1 doi: 10.1016/0014-2999(84)90225-5 – ident: e_1_2_1_5_1 doi: 10.1111/j.1476-5381.1967.tb02148.x – ident: e_1_2_1_20_1 doi: 10.1007/BF01897474 – volume-title: Scientific Tables Geigy (Statistics) year: 1980 ident: e_1_2_1_6_1 contributor: fullname: GEIGY – ident: e_1_2_1_14_1 doi: 10.1038/218144a0 – volume: 332 start-page: R60 year: 1986 ident: e_1_2_1_24_1 article-title: Inhibition of converting enzyme in isolated arterial preparations with intact or disrupted endothelium publication-title: Naunyn-Schmiedebergs Arch. Pharmacol. contributor: fullname: SCHÖLKENS B.A. – ident: e_1_2_1_23_1 doi: 10.1097/00004872-198812040-00004 |
SSID | ssj0014775 |
Score | 1.4432787 |
Snippet | 1
The activity of angiotensin converting enzyme (ACE) has been studied on functional parameters of intact isolated preparations of extrapulmonary tissues. The... 1. The activity of angiotensin converting enzyme (ACE) has been studied on functional parameters of intact isolated preparations of extrapulmonary tissues. The... The activity of angiotensin converting enzyme (ACE) has been studied on functional parameters of intact isolated preparations of extrapulmonary tissues. The... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 49 |
SubjectTerms | Angiotensin II - metabolism Angiotensin-Converting Enzyme Inhibitors - pharmacology Animals Antihypertensive agents Biological and medical sciences Blood Pressure - drug effects Bradykinin - physiology Captopril - pharmacology Cardiovascular system Endothelium, Vascular - drug effects Endothelium, Vascular - physiology Female Guinea Pigs Ileum - drug effects In Vitro Techniques Lung - metabolism Male Medical sciences Muscle, Smooth - enzymology Muscle, Smooth, Vascular - enzymology Norepinephrine - pharmacology Peptidyl-Dipeptidase A - metabolism Pharmacology. Drug treatments Rabbits Rats Rats, Inbred Strains Uterine Contraction - drug effects Vasoconstriction - drug effects |
Title | Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1476-5381.1990.tb12050.x https://www.ncbi.nlm.nih.gov/pubmed/2164861 https://search.proquest.com/docview/15626432 https://search.proquest.com/docview/79889888 https://pubmed.ncbi.nlm.nih.gov/PMC1917461 |
Volume | 100 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFD40hcFgjN3K3KseRp_qxBdJth-3bl0YdOShhbwZSZazQKOExIGlv75Hkp02bHvowA_GkmWs78j6jnXOJ4BPlaqLVKk8rCMpQoozSlgot4QYMck1ZaK2Cc7XP_nwlv4Ys_EesC4XxgXtKzntm7tZ30x_udjKxUwNujixwej60voYlMeDHvSyNO1c9HbpgGaZ37bAqh_Ged4qjbbhOzTjIY7x2GbpRf1GxknEIqtG_SJBxyHn8c789GohVthVtd_j4m8k9M9Yyqcc101SV2_gdcsuyWf_Fm9hT5t3cD7y8tSbC3LzmG21uiDnZPQoXL15D5OvembpojcKMq8Jfrmx_voOL4vlhtgkCLvXhC0SZjKdu_B3Q1zoupUjmBBt7jczTfDi1DRYnzQOWbJYaq8yjg_4ALdX324uh2G7EUOosK-isOJIAhE3LtOKaZpajfyES_xmp6LgiRIFjRHyvEhkJnNaqLpGasCQCfIqUTxKD2DfzI3-CIRJxdGDqkTEK4r3F1rXTDOJrWaqSqIA0q77y4XX2yif-ikZLy18pYWvbOErfwdwsoPU9lae29802OpZh1yJw8euiQij5-tVie4rUsI0-XcNK-iGRx7AgUd623hrMQFkOyawLbfK3bslaNBOwbs14AAKZyzPeNPyy2joTg__-6lH8NK26aM2j2G_Wa71CTKrRp5C7_s4PnXj6QGFpSO_ |
link.rule.ids | 230,315,733,786,790,891,27946,27947,53816,53818 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbGEAIJcZ8IMOYHtKclzcV2kkcYTAXWqQ8d2psVO06pWNOqTSW6X885dtKtXB6G1IcqvkRJvuh8J_7OZ0LelbrKE60zvwpV4TOIKH6u7RJiyJUwjBcVFjgPzkT_nH254Bc7hHe1MFa0r9UkqC-nQT35brWV86nudTqx3nBwjDkGE1HvDrnLceGrS9LbxQOWpm7jAvQ_jLKs9RptBTwsFT6Owjq9MGhUFIc8RD_qezGkDpmItiLUw3mxhJtVuV0u_kZD_1RT3mS5NkydPCbfugt06pQfwapRgb76zfvx1nfgCXnUElf63jU_JTumfkYOh875en1ER9eFXMsjekiH157Y6-dk_NFMkYk6vNFZRSEoQP_VJRwuFmuK9RW4jQU2FfV4MrPK-ppaVTw6HYypqa_WU0Ph4KRuoD9tLGjofGGcgTmc4AU5P_k0Ou777R4PvoaHEPqlAH4JkBAqKblhCdrvx0JBOEiKXMS6yFkEaMryWKUqY7muKmAdHEimKGMtwmSP7Naz2rwklCstIDkri1CUDMbnxlTccAWzprqMQ48k3XOVc2flIW-mQKmQiAuJuJAtLuRPj-xvQWAzVGT4BQhmPeggIeHNxOWWojaz1VJCZgxsM4n_3QO94uCXeWTPQWgzeQtFj6Rb2Nq0oyn4dgsgxZqDt8jwSG5ReIsrlR-Gffv31X-f9YDc748Gp_L089nX1-QBzu_EoW_IbrNYmX0gcI16a1_XX78YRME |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwGLVgCISEuG4iwJgf0J6WNBfbSR5hoyqXTXnYpIkXK3acUrG6UZtKdL-ez3bStVwemNSHKr5ESU70nS8-Ph9C7ypZ54mUmV-HovQJRBQ_l3YJMaSCKULL2mxwPj1jowvy-ZJebpT6sqJ9KSaBvpoGevLdaiubqRz0OrFBcXpscgzCokFT1YO76B41UadP1LsFBJKmrniB8UCMsqzzG-1EPCRlvhll9uqFQSuiOKSh8aS-H0P6kLFoK0o9asoF3LDaVbr4GxX9U1G5yXRtqBo-Qd_6i3QKlR_BshWBvP7N__FWd-EpetwRWPzedXmG7ij9HB0WzgF7dYTPbzZ0LY7wIS5uvLFXL9D4RE0NI3W4w7MaQ3CA_ssrOFzOV9jsszDlLExTqceTmVXYa2zV8cbxYIyVvl5NFYaDE91Cf9xa8OBmrpyROZxgF10MP54fj_yu1oMv4UGEfsWAZwI0mEgqqkhibPhjJiAsJGXOYlnmJAJUZXksUpGRXNY1sA8KZJNVsWRhsod29EyrlwhTIRkkaVUZsorA-FypmioqYNZUVnHooaR_trxxlh58MxVKGTfY4AYbvMMG_-mh_S0YrIeyzHwJglkPelhweEPNskup1Wy54JAhA-tM4n_3MJ5x8Ms8tOdgtJ68g6OH0i18rduNOfh2C6DFmoR36PBQbpH4H1fKPxQj-_fVrc96gB4UJ0P-9dPZl9fooZneaUTfoJ12vlT7wONa8da-sb8A029HQQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Demonstration+of+extrapulmonary+activity+of+angiotensin+converting+enzyme+in+intact+tissue+preparations&rft.jtitle=British+journal+of+pharmacology&rft.au=Lembeck%2C+F.&rft.au=Griesbacher%2C+T.&rft.au=Eckhardt%2C+M.&rft.date=1990-05-01&rft.issn=0007-1188&rft.eissn=1476-5381&rft.volume=100&rft.issue=1&rft.spage=49&rft.epage=54&rft_id=info:doi/10.1111%2Fj.1476-5381.1990.tb12050.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1476_5381_1990_tb12050_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1188&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1188&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1188&client=summon |